Epigenomics AG ECX.DE

€0.70 €0.18 (34.62%) 1D

Last Updated: Jun 27, 12:00 AM·XDUS

ECX.DE Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: February 09, 2024

Report Source: 2023 2nd Quarter Report

Analyst's Ratings for Epigenomics AG (ECX.DE)

Based on 6 analysts giving stock ratings to Epigenomics AG in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
50
Hold
17
Sell
0
Strong Sell
0
Epigenomics AG

Epigenomics AG. Stock Analysis ECX.DE

Germany Health Care Nano Cap Report:
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Berlin, Berlin and currently employs 18 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
Read More

Epigenomics AG (ECX.DE) Chart

Key Statistics of Epigenomics AG (ECX.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.52€0.70

Today's Open

€0.52

Volume

5061.00

P/E Ratio (TTM)

-

52 Week Range

€0.30€0.70

Market Cap

-

Avg. Volume

-

Dividend Yield

-

Financial Metrics & Statements of Epigenomics AG (ECX.DE)

FAQ's for Epigenomics AG (ECX.DE)

  • According to Musaffa’s Shariah screening methodology, Epigenomics AG (ECX.DE) is currently classified as HALAL as of February 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.